Aizon

An AI model that performs well in a notebook is the easy part of this work. Operationalizing AI in a validated GMP environment is the hard part. And it's the part almost nobody demonstrates. We've spent years on this problem at Aizon. Accuracy alone does not make a model validatable. You have to show control and explain it: how it was trained, how it behaves at the edges, how you catch and document drift, and when it is archived but always accessible for audit and inspections. Then multiply that by every model you run. Think of each one like a new operator on the floor: you would never let it run a critical step without a training record, a defined scope, and someone supervising. One operator is manageable. Ten operators with no system behind them is chaos, and ten models with no governance are the same. You need versioning, audit trails, human oversight, and a framework compliant with 21 CFR Part 11 and Annex 11 from day one. This is where most pharma AI programs stop working. The science is strong but there's no framework and scalable technology to run it in production yet. Here is the part we are optimistic about: the regulators are ahead of most of the industry, and the teams that solve this, design for it early. A model that holds up under GxP is what turns a promising scientific tool into more reliable medicine for the patients waiting on it. On September 14 in Barcelona, we're putting 50 manufacturing leaders in a room to work through exactly this. We'll look at proven AI implementations presented by real pharma manufacturing peers, including a fireside chat on GMP and data integrity validation. If you've put an ML model into GMP production, how did you handle QA sign-off? Join us in Barcelona and let's discuss. Sign up: https://lnkd.in/eZJKbKse #GMP #PharmaManufacturing #AI

Most AI pilots in pharma stall — not because the technology fails, but because they start in the wrong place, with no clear line to the P&L. The GMP AI Use Case Matrix sequences use cases by the role that feels the pain and the outcomes they move: yield, release speed, deviations, and uptime. One framework, from where you are today to network-wide impact. Free download ⬇️

Every pharma site knows AI can lift yield and quality. The hard part isn't ambition, it's knowing which use case to run first, and in what order. The GMP AI Use Case Matrix maps the highest-impact use cases to your digital maturity, your stakeholders, and your P&L, so you walk into your next ops review knowing exactly where to start. Free download ⬇️

Every pharma site knows AI can lift yield and quality. The hard part isn't ambition — it's knowing which use case to run first, and in what order. The GMP AI Use Case Matrix maps the highest-impact use cases to your digital maturity, your stakeholders, and your P&L — so you walk into your next ops review knowing exactly where to start. Free download ⬇️

EU GMP Annex 1 requires real-time alarm acknowledgment, trend analysis, and a unified data timeline linking alarm events to batch context and process steps. Many sterile manufacturers are operating dozens of machines with alarm data siloed across disconnected systems — with no compliant, unified view. Aizon Unify aggregates alarm event data from across your manufacturing systems, contextualizes every event against batch IDs, process steps, and equipment state, and produces the contextualized, batch-linked evidence your release decisions require.

Your manufacturing floor runs on a dozen systems that don't talk to each other. Every analytics request turns into an IT project. Every integration adds complexity. Aizon Unify connects to your historians, MES, LIMS, QMS, and ERP — without replacing any of them. Single-tenant AWS. ISO 27001 certified. GxP-compliant from day one. Your data stays yours.